Recombinant multi-species NKX2-5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NKX2-5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a homeobox-containing transcription factor. This transcription factor functions in heart formation and development. Mutations in this gene cause atrial septal defect with atrioventricular conduction defect, and also tetralogy of Fallot, which are both heart malformation diseases. Mutations in this gene can also cause congenital hypothyroidism non-goitrous type 5, a non-autoimmune condition. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
The Alternative Names of target: CHNG5,CSX,CSX1,Cardiac-specific homeobox,Csx,HLHS2,Homeobox protein CSX,Homeobox protein NK-2 homolog E,Homeobox protein Nkx-2.5,NKX2-5,NKX2.5,NKX2E,NKX4-1,Nkx-2.5,Nkx2-5,Nkx2.5,VSD3,tinman
Go
to NKX2-5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP5812-Ag-1/ GM-Tg-hg-IP5812-Ag-2 | Human NKX2-5 protein | Human |
| GM-Tg-rg-IP5812-Ag-1/ GM-Tg-rg-IP5812-Ag-2 | Rat NKX2-5 protein | Rat |
| GM-Tg-mg-IP5812-Ag-1/ GM-Tg-mg-IP5812-Ag-2 | Mouse NKX2-5 protein | Mouse |
| GM-Tg-cynog-IP5812-Ag-1/ GM-Tg-cynog-IP5812-Ag-2 | Cynomolgus/Rhesus macaque NKX2-5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP5812-Ag-1/ GM-Tg-felg-IP5812-Ag-2 | Feline NKX2-5 protein | Feline |
| GM-Tg-cang-IP5812-Ag-1/ GM-Tg-cang-IP5812-Ag-2 | Canine NKX2-5 protein | Canine |
| GM-Tg-bovg-IP5812-Ag-1/ GM-Tg-bovg-IP5812-Ag-2 | Bovine NKX2-5 protein | Bovine |
| GM-Tg-equg-IP5812-Ag-1/ GM-Tg-equg-IP5812-Ag-2 | Equine NKX2-5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP5812-Ag-1/ GM-Tg-hg-IP5812-Ag-2;
GM-Tg-rg-IP5812-Ag-1/ GM-Tg-rg-IP5812-Ag-2;
GM-Tg-mg-IP5812-Ag-1/ GM-Tg-mg-IP5812-Ag-2; GM-Tg-cynog-IP5812-Ag-1/ GM-Tg-cynog-IP5812-Ag-2; GM-Tg-felg-IP5812-Ag-1/ GM-Tg-felg-IP5812-Ag-2; GM-Tg-cang-IP5812-Ag-1/ GM-Tg-cang-IP5812-Ag-2; GM-Tg-bovg-IP5812-Ag-1/ GM-Tg-bovg-IP5812-Ag-2; GM-Tg-equg-IP5812-Ag-1/ GM-Tg-equg-IP5812-Ag-2 |
| Products Name | NKX2-5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NKX2-5 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NKX2-5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.